| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate |
2009-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2011-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2011511024-A |
| titleOfInvention |
N- [3-Bromo-2-chloro-4- (4,5-dihydro-1H-imidazol-2-ylmethyl) -phenyl] -methanesulfone as an alpha-1A adrenergic partial agonist for the treatment of urinary incontinence Amide |
| abstract |
The present invention relates to an α-1A receptor partial agonist represented by the formula (I), and a pharmaceutically acceptable salt or solvate thereof. The invention further relates to pharmaceutical compositions containing the formula (I), methods for their use as therapeutic agents, and methods for their production. |
| priorityDate |
2008-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |